Proud to Present Dr. John Berk’s Research in hereditary ATTR Amyloidosis in New England Journal of Medicine

We are proud to announce 2 publications in the New England Journal of Medicine highlighting Dr. John Berk’s research in hereditary ATTR amyloidosis. You can find both articles linked below.

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
NEJM | PubMed

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
NEJM | PubMed

Congratulations to Dr. Berk!

View all posts